We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.25 | 17.50 | 19.00 | 18.25 | 18.25 | 18.25 | 144,329 | 07:39:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.43 | 16.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/10/2019 16:20 | Whitegold, I had the same with my doctor, who told me to send in a Rep. DIAMOND. | diamond fibre | |
16/10/2019 16:17 | Let's not forget folks, here - verbatim - is 1 nhs just 2 days ago, telling us what he thinks of Opti: "14/10/2019 17:46 MARKET CAP £50M A fair valuation on hope value might be £10M 1 nhs." The man's clearly one biotix short of an opti. | lord loads of lolly | |
16/10/2019 16:16 | Not only do I have faith in SOH, but I also have the same faith in Elrico. DIAMOND. | diamond fibre | |
16/10/2019 16:14 | elrico - I suggest you read through today's posts here, then break off any further discussions with 1nhs. His agenda is quite clear. | lord loads of lolly | |
16/10/2019 16:11 | I thought you would have felt let down after all your hard work, only to see the stock slump. After reading through your articles I can now see your spot on, and are about to be rewarded. | 1 nhs | |
16/10/2019 16:03 | NHS, why have I been let down? Markets can be exceptionally irrational for longer than some investors can stay solvent. There is a perception H1 was poor and there are several reasons for this; Main 3 1. SOH built-up expectations up too much with the hockey stick analogy Personally, I'm of the opinion he was referring to YoY not periodically as most assumed. 2. PI's expectations were unreasonable 3. Lack of understanding of how the B2B model & time it takes to develop | elrico | |
16/10/2019 15:55 | Plasybryn, I will post a link to the main page on MM BB. If I post it here Someulose will remove it. | elrico | |
16/10/2019 12:32 | Thanks. Does that mean it isn't for general circulation? | plasybryn | |
16/10/2019 11:04 | Malkee - the more individuals who tell their docs, the greater the general awareness. I only wish each tablet were 50p ... cant have everything though !! Lol. | whitegold1 | |
16/10/2019 10:57 | My doctor said he would prescribe it if he could. I have been on X3 for 12 months now and have reduced my statin dosage by half to 10mg | malkee | |
16/10/2019 10:37 | Just a heads up. My consultant has suggested I continue with my Cholbiome x3 but add in Pravastatin x2/wk to gain ' additional' stroke / heart attack protection. He was quite happy with my ldl/hdl ratio, triglycerides on Cholbiome alone although he hadnt heard of it which I thought was odd. He was keen on the gut biome mechanism stuff mind. Surely we need to target medical professionals to raise awareness of Opti in general. Clearly, they cant prescribe it but awareness increases may be worthwhile. | whitegold1 | |
16/10/2019 10:27 | You have to review the share price history. This hit 120p+ on previous news. We are now in a way better position now with GRS status both in the EU and USA and GMP. These are clearly door openers - to big revenues. The cost base is still low. There has to be some more big news around the corner and maybe a holdings rns or 2. I dont want us to be taken out forca paltry premium. Onwards and upwards. Brexit deal might help too - if the politicians can stop their one upmanship. GL to genuine LTH.s - you know who you are. The others, peasants of the first order. | whitegold1 | |
16/10/2019 10:04 | The note has been loaded in the lemming google groups. | slartybartfaster |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions